Analysing new treatment options for Adenoid Cystic Carcinoma (ACC)
Full project title: Analysis of new therapeutic options for adenoid cystic carcinoma
Tag: New treatment
![Research-icon-new-treatment <strong>Tag:</strong> New treatment](https://oraclehnc.org.uk/wp-content/uploads/2019/01/Research-icon-new-treatment-150x150.png)
![Alexandra-Rose Alexandra Rose](https://oraclehnc.org.uk/wp-content/uploads/2019/01/Alexandra-Rose-300x226.jpg)
Project type:
PhD Research
Project Leader:
Dr Amanda Swain
Professor Kevin Harrington
Researcher:
Alexandra Rose
Commencement date:
October 2016
Length of project:
4 years
Funding provided:
£155,070
Funder:
See above
Location:
The Institute of Cancer Research
New and improved therapies are urgently required for ACC, with the 15 year survival rate as low as 40%. One reason for this low rate is that ACC recurrence is common and often spreads to the lungs and perineural space, where the tumour develops chemotherapy resistance which significantly reduces treatment options.
![Dr-Amanda-Swaine Dr Amanda Swain](https://oraclehnc.org.uk/wp-content/uploads/2019/01/Dr-Amanda-Swaine.jpg)
Help fund this project
For more information on funding our Research Projects please email us
Donate now and together we can save more lives by beating cancer sooner.